Identification of dual agonistic novel ligands for insulin receptor and pparγ through molecular docking

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue SUPPL. 4, 2012, Pages 142-147

  Pitchai, Daisy ^a   Lizzy Jaculine, A ^a   Manikkam, Rajalakshmi ^a  

^a HOLY CROSS COLLEGE   (India)

Author keywords

Diabetes mellitus; Dual agonists; Insulin receptor; Novel gymnemic diacetate and Novel gymnemic triacetate; PPAR

Indexed keywords

CATECHIN; COSTUNOLIDE; DIHYDROXYGYMNEMIC TRIACETATE; EREMANTHIN; GALLIC ACID; GYMNEMIC DIACETATE; GYMNEMIC TRIACETATE; INSULIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT MEDICINAL PRODUCT; SAPONIN; UNCLASSIFIED DRUG;

ARTICLE; COMPUTER PROGRAM; DIABETES MELLITUS; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; INSULIN DEFICIENCY; INSULIN RESISTANCE; MOLECULAR DOCKING; MOLECULAR MODEL; NONHUMAN;

EID: 84866339804     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Metha Hiren, Patel Paresh, Patel Kamlesh, Mazhvancherli Tikson, Dapagliflozin. Newer mollecule for treatment of Type-2 diabetes mellitus; Int. Res. J. Pharm. 2011; 2(1): 2230-8407.
2. Sachdewa A, Khemani LD. Effect of Hibiscus rosa sinensis Linn. ethanol flower extract on blood glucose and lipid profile in streptozotocin-induced diabetes in rats; J. Ethnopharmacol. 2003; 89: 61-66.
3. Soumya Prakash Rout KA. Choudary DM. Kar, Lopamudra Das, Avijeet Jain. Plants in traditional medicinal system-future source of new drugs; Int. J. Pharm and Pharmaceutical Sci. 2009; 1:1-23.
4. Lieu JP, Zhang M, Wang WY, Grimsgaard S. Chinese herbal medicines for type-2 diabetes mellitus;Cochrane Database Syst. Rev. 2004; 3: 3642.
5. Vuksan V, Sievenpiper JL. Herbal remedies in the management of diabetes: lessons learned from the study of ginseng; Nutr. Metabol. Cardiovasc. Dis. 2005; 15: 149-160.
6. Johnson L, Strich H, Taylor A, Timmermann B, Malone D, Teufel-Shone N, Drummond R, Woosley R, Pereira E, Martinez A. Use of herbal remedies by diabetic Hispanic women in the southwestern United States; Phytother. Res. 2006;20: 250-255.
7. Jung M. Park M, Lee HC, Kang YH, Kang ES, Kim SK. Antidiabetic agents from medicinal plants; Curr. Med. Chem. 2006; 13: 1203-1218.
8. Matsui T, Ogunwande IA, Abesundara KJM, Matsumoto K. Antihyperglycemic potential of natural products; Mini Rev. Med. Chem. 2006; 6: 109-120.
9. Bharti D. Talele, Raghunath T. Mahajan, Manojkumar Z. Chopda And Namrata V. Nemade. Ne Phroprotective Plants: A Review; Int. J Pharm and Pharmaceutical Sci. 2012; 4: 8-16
10. Walker AB, Naderali EK, Chattington PD, Buckingham RE, Williams G. Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro; Diabetes. 1998; 47: 810-814.
11. Brodsky IG, Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ. Therapeutic Strategies for the the treatment of insulin resistance; Modern Nutrition in Health and Disease. 2006; 10: 54-63.
12. Daisy P, Balasubramanian K, Rajalakshmi M, Eliza J, Selvaraj J. Insulin mimetic impact of Catechin isolated from Cassia fistula on the glucose oxidation and molecular mechanisms of glucose uptake on Streptozotocin-induced diabetic Wistar rats; Phytomed. 2010; 17(1): 28-36.
13. James Eliza, Pitchai Daisy, Savarimuthu Ignacimuthu, Veeramuthu Duraipandiyan. Normo-glycemic and hypolipidemic effect of costunolide isolated from Costus speciosus (Koen ex. Retz.)Sm. in streptozotocin-induced diabetic rats; Chem Biol Interact. 2009; 179(2-3): 329-34.
14. Eliza J, Daisy P. Ignacimuthu S. Antioxidant activity of costunolide and eremanthin isolated from Costus speciosus (Koen ex. Retz) Sm; Chem Biol Interact. 2010; 188: 467-472.
15. Daisy P, Eliza J, Mohamed Farook KA. A novel dihydroxy gymnemic triacetate isolated from Gymnema sylvestre possessing normoglycemic and hypolipidemic activity on STZ-induced diabetic rats; J. Ethnopharmacol. 2009; 126(2): 339344.
16. Cecily Rosemary Latha R, Daisy P. Insulin-secretagogue, antihyperlipidemic and other protective effects of gallic acid isolated from Terminalia bellerica Roxb. in streptozotocin-induced diabetic rats; Chem Biol Interact. 2011; 189: 112-118.
17. Daisy P, Salu Mathew, Suveena S, Nirmala Rayan A. A Novel Terpenoid from Elephantopus scaber-Antibacterial Activity on Staphylococcus Aureus: A Substantiate Computational Approach; Int. J. Biomed. Sci. 2008;4(3): 196-203.
18. Ganguly S, Mazumder M, Basu P, Roy P, Mitra S, Datta A. In silico screening of herbal and nanoparticle lead compounds for effectivity against H5N1, H1N1 neuraminidase and telomerase; BMC Bioinformatics. 2010; 11-13.
19. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings; Adv. Drug Delivery Rev. 1997; 23: 3-25.
20. Prentis RA, Lis Y, Walker SR. Pharmaceutical innovations by the seven UK owned pharmaceutical Companies; Brit. J. Clin. Pharm. 1988; 25: 387-396.
21. Richard AM, Benigni R. SAR approaches for predicting chemical carcinogenicity: survey and status report; SAR and QSAR in Environ. Res. 2002; 13: 1-19.
22. Virupakshaiah DBM, Kelmani C, Patil R, Hegade P. World Academy of Science, Engineering and Technology, 2007;30: 297-299.
23. Pyne S, Gatathri P. Geometric Methods in Molecular Docking; Bioinfo. 2005; India. J. III 11-12.
24. Fantin VR, Sparling JD, Slot JW, Keller SR, Lienhard GE, Lavan BE. Characterization of insulin receptor substrate 4 in human embryonic kidney 293 cells; J. Biol. Chem. 1998; 273: 1072610732.
25. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signaling pathways: insights into insulin action; Nat. Rev. 2006; 7: 85-96.
26. Florian B, Yasunori T, Everen C. Obdesity peroxisome proliferator-activated receptors and Atheroscierosis in Type-2 diabetes; Atherosclerosis thrombosis and vascular Biol. 2006; 26: 28-40.